|
MechanismKRAS gene modulators |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Oncogenuity, Inc.
0 Patents (Medical) associated with Oncogenuity, Inc.
100 Deals associated with Oncogenuity, Inc.
100 Translational Medicine associated with Oncogenuity, Inc.